Fulton Bank, N.A. Dexcom Inc Transaction History

Fulton Bank, N.A.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 06, 2023	BUY	$112.47 - $130.98 $9,897 - $11,526	88 Added 3.01%	3,013 $387,000
Q1 2023 Apr 06, 2023	BUY	$104.0 - $122.92 $26,104 - $30,852	251 Added 9.39%	2,925 $339,000
Q4 2022 Jan 05, 2023	BUY	$84.98 - $122.67 $8,073 - $11,653	95 Added 3.68%	2,674 $303,000
Q3 2022 Oct 04, 2022	BUY	$76.35 - $94.18 $196,906 - $242,890	2,579 New	2,579 $208,000
Q2 2022 Jul 07, 2022	SELL	$67.99 - $132.89 $39,162 - $76,544	-576 Closed	0 $0
Q1 2022 Apr 05, 2022	BUY	$94.08 - $130.2 $11,195 - $15,493	119 Added 26.04%	576 $295,000
Q4 2021 Jan 05, 2022	SELL	$129.87 - $162.82 $3,376 - $4,233	-26 Reduced 5.38%	457 $246,000
Q3 2021 Oct 05, 2021	SELL	$106.71 - $143.18 $1,173 - $1,574	-11 Reduced 2.23%	483 $264,000
Q2 2021 Jul 06, 2021	BUY	$80.99 - $107.93 $40,009 - $53,317	494 New	494 $211,000

1,024

352M

5.51M

5.61M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.6B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Fulton Bank, N.A., based on Form 13F filings with the SEC.

Stay updated on Fulton Bank, N.A. with notifications on news.